EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway

Amit K Tripathi, Priyanka P Desai, Antariksh Tyagi, Jana B Lampe, Yogesh Srivastava, Michael Donkor, Harlan P Jones, Sergei V Dzyuba, Eric Crossley, Noelle S Williams, Jamboor K Vishwanatha

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.105680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Amit K Tripathi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas, USA. Electronic address: ami…. Hauptthemen laut MEDLINE: Intracellular Signaling Peptides and Proteins, Neoplasm Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIMHD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migration and invasion enhancer 1 (MIEN1) overexpression characterizes several cancers and facilitates cancer cell migration and invasion. Leveraging conserved immunoreceptor tyrosine-based activation motif and prenylation motifs within MIEN1, we identified potent anticancer peptides. Among them, bioactive peptides LA3IK and RP-7 induced pronounced transcriptomic and protein expression changes at sub-IC50 concentrations. The peptides effectively inhibited genes and proteins driving cancer cell migration, invasion, and epithelial-mesenchymal transition pathways, concurrently suppressing epidermal growth factor-induced nuclear factor kappa B nuclear translocation in metastatic breast cancer cells. Specifically, peptides targeted the same signal transduction pathway initiated by MIEN1. Molecular docking and CD spectra indicated the formation of MIEN1-peptide complexes. The third-positioned isoleucine in LA3IK and CVIL motif in RP-7 were crucial for inhibiting breast cancer cell migration. This is evident from the limited migration inhibition observed when MDA-MB-231 cells were treated with scrambled peptides LA3IK SCR and RP-7 SCR. Additionally, LA3IK and RP-7 effectively suppressed tumor growth in an orthotopic breast cancer model. Notably, mice tolerated high intraperitoneal (ip) peptide doses of 90 mg/Kg well, surpassing significantly lower doses of 5 mg/Kg intravenously (iv) and 30 mg/Kg intraperitoneally (ip) used in both in vivo pharmacokinetic studies and orthotopic mouse model assays. D-isomers of LA3IK and RP-7 showed enhanced anticancer activity compared to their L-isomers. D-LA3IK remained stable in mouse plasma for 24 h with 75% remaining, exhibiting superior pharmacokinetic properties over D/L-RP-7. In summary, our findings mark the first report of short peptides based on MIEN1 protein sequence capable of inhibiting cancer signaling pathways, effectively impeding cancer progression both in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracellular Signaling Peptides and ProteinsNeoplasm ProteinsAnimalsMiceCell MovementCell ProliferationEpithelial-Mesenchymal TransitionMolecular Docking SimulationSignal TransductionHumansCell LineNeoplasmsMembrane GlycoproteinsMolecular Chaperones

Stichwörter der Autor:innen

anticancer peptidesbreast cancercancer biologyepidermal growth factor (EGF)epithelial-mesenchymal transition (EMT)peptide designpharmacokineticsprotein motif

Substanzen

Intracellular Signaling Peptides and ProteinsNeoplasm ProteinsMIEN1 protein, humanCLN3 protein, humanMembrane GlycoproteinsMolecular Chaperones

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas, USA. Electronic address: amitkumar.tripathi@unthsc.edu.
  • Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas, USA.
  • Yale Center for Genome Analysis (YCGA), Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Chemistry and Biochemistry, Texas Christian University, Fort Worth, Texas, USA.
  • Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS
  • National Institutes of Health
  • Summerfield G Roberts Foundation

Zitieren

APA

Tripathi, A. K., Desai, P. P., Tyagi, A., Lampe, J. B., Srivastava, Y., Donkor, M., Jones, H. P., Dzyuba, S. V., Crossley, E., Williams, N. S., & Vishwanatha, J. K. (2024). Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.105680

Vancouver

Tripathi AK, Desai PP, Tyagi A, Lampe JB, Srivastava Y, Donkor M, et al. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.105680

BibTeX
@article{Tripathi2024,
  author = {Tripathi, Amit K and Desai, Priyanka P and Tyagi, Antariksh and Lampe, Jana B and Srivastava, Yogesh and Donkor, Michael and Jones, Harlan P and Dzyuba, Sergei V and Crossley, Eric and Williams, Noelle S and Vishwanatha, Jamboor K},
  title = {Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.105680}
}
Kostenlos starten →